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Abstract
Background: Caregivers of care-recipients with mild cognitive impairment (MCI) or dementia experience high
caregiver burden; however, the psychiatric burden of caregivers of care-recipients with subjective cognitive decline
(SCD) has not been investigated. We aimed to explore the prevalence of and risk factors for anxiety and depression
symptoms among the caregivers of care-recipients with SCD and cognitive impairment.
Methods: The Hospital Anxiety and Depression Scale (HADS) was used to examine the anxiety and depression
symptoms among the caregivers of 343 care-recipients (84 with SCD, 120 with MCI and 139 with dementia) treated
at the Memory Clinic of Huashan Hospital in Shanghai, China from May 2012 to October 2014. A logistic regression
was used to explore the factors associated with caregiver’s anxiety and depression symptoms.
Results: In total, 26.5 % of caregivers had anxiety symptoms, and 22.4 % had depression symptoms. Totals of 17.9,
30.0 and 28.8 % of caregivers of care-recipients with SCD, MCI or dementia, respectively, had anxiety symptoms
(P = 0.1140), whereas 22.6, 24.2 and 20.9 %, respectively, had depression symptoms (P = 0.8165). The risk factors
for caregiver’s anxiety symptoms were increased caregiver age as well as having care-recipients who were male,
had higher Cohen Mansfield Agitation Inventory (CMAI) scores, and higher Geriatric Depression Scale (GDS) scores.
The risk factors for caregiver’s depression symptoms were increased caregiver age as well as caring for care-recipients
with MCI or SCD, those with lower Toronto Empathy Questionnaire (TEQ) scores, and those with higher GDS scores.
Conclusions: Caregivers of care-recipients with SCD showed the same level of depression symptoms as those of
care-recipients with MCI. Caregiver’s depression and anxiety symptoms were associated with their care-recipients’
psychiatric and behavioral syndromes.
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Background
Caregiver burden is common in dementia. This condi-
tion is not only associated with adverse emotional
states and psychiatric morbidity but also poorer
physical condition and worse financial and social conse-
quences. Factors in three other domains are also relevant:
care-recipient characteristics, caregiver characteristics and
living conditions [1–3]. Previous studies have reported
that approximately 22 % of caregivers experience clinical
depression [4], and approximately 75 % of caregivers
experience significant depression and anxiety symptoms
[5, 6]. Mild cognitive deficits are not sufficient for a
diagnosis of dementia; however, care-recipients with mild
cognitive impairment (MCI) have a 10–12 % annual
probability of progression to dementia [7–11]. One study
also indicated that caregivers of care-recipients with MCI
showed anxiety and depression symptoms [12].
Subjective cognitive decline (SCD) in older adults is
increasingly recognized as a potential indicator of non-
normative cognitive decline, and some people with this
condition eventually progress to dementia [13–17]. The
core of the definition of SCD is self-experienced concerns
about persistent decline in one or more aspects of cognitive
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function that are typically informant-corroborated; how-
ever, they show no impairment in activities of daily living
and typically scores within normal limits on standard
neuropsychological tests [18–20]. A previous study showed
that the annual conversion rate (ACR) of SCD to dementia
is 2.33 % (95 % CI: 1.93–2.78 %), and that of SCD to MCI
is 6.67 % (95 % CI: 4.70–8.95 %) [17].
Regarding the persistent cognitive decline and the high
rate of its conversion, we assumed that both care-
recipients and their caregivers would suffer from cogni-
tive complaints. However, psychiatric symptoms among
SCD-caregivers have been under-researched. This study
explored the prevalence of and risk factors for anxiety
and depression symptoms among caregivers of care-
recipients with SCD and cognitive impairment using




A hospital-based cross-sectional survey of 343 pairs of
care-recipients and their caregivers was conducted at the
Memory Clinic of Huashan Hospital in Shanghai from
May 2012 to October 2014. A caregiver was defined as
someone who spent at least 8 h per week caring for a
care-recipient, regardless of whether they lived together.
The inclusion criteria were: the care-recipient was diag-
nosed with mild or moderate dementia, MCI or SCD;
one primary caregiver cared for one care-recipient; the
principal family caregiver was over 18 years old and took
care of or lived with the care-recipient; the caregiver’s
relationship with the care-recipient and their caring time
were also considered when recruiting participants,
therefore, spouses, daughters, sons, daughters-in-law and
other relatives were included, regardless of whether they
lived with their care-recipients. Those who simultaneously
provided care for another family member with a chronic
medical condition were excluded.
Demographic factors and medical history
Demographic characteristics, including age, gender and
education, were collected from the care-recipients and
their caregivers. Additional information was collected
regarding the caregiver such as their working status,
experience in caring for care-recipients with dementia,
familiarity with the care-recipient and their relationship
with the care-recipient.
Neurological, psychiatric and neuropsychological
assessments
For each care-recipient, cognitive function scales cover-
ing domains of global cognition (i.e., executive function,
visuospatial ability, memory, language and attention)
were administered, including the Mini Mental State
Examination (MMSE) [21], the Memory and Executive
Screening (MES) [22], the Montreal Cognitive Assess-
ment (MOCA) [23], the Rey-Osterrieth Complex Figure
Test (CFT) [24], the Stroop Color Word Test (CWT)
[25], the Boston Naming Test (BNT) [26], the Auditory
Verbal Learning Test (AVLT) [27], the Symbol Digit
Modalities Test (SDMT) [28], the Event-Based Prospect-
ive Memory Test (EBPM) and the Time-Based Prospect-
ive Memory Test (TBPM) [29, 30], the Animal Verbal
Fluency Test (VFT) [31],the Trail Making Test (TMT)
[32], the Judgement of Line Orientation (JLO) [33], the
Word Memory Test (WMT) [34],the Visual Object and
Space Perception (VOSP) [35], and the Clinical Demen-
tia Rating Scale (CDR) [36]. Furthermore, the Geriatric
Depression Scale (GDS) [37] and the Zung Self-Rating
Anxiety Scale (ZSAS) [38] were also administered for
each care-recipient. For each caregiver, the 16-item ver-
sion of the Informant Questionnaire on Cognitive Decline
in the Elderly (IQCODE) [39], the Toronto Empathy
Questionnaire (TEQ) [40], the Cohen-Mansfield Agitation
Inventory (CMAI) [41] and the Apathy Evaluation Scale
(AES) [42] were administered to evaluate the psychiatric
and neuropsychological symptoms of care-recipients.
The Hospital Anxiety and Depression Scale (HADS) is
a popular clinical and research instrument used to
screen for anxiety and depression symptoms in both
hospital and community settings [43, 44]. The HADS
facilitates the early identification of both anxiety and de-
pression symptoms simultaneously; furthermore, it pro-
vides a separate score for each domain. It is easy to
score and simple to interpret. The Chinese version of
the HADS is available and shows acceptable reliability
and validity [45–47]. Therefore, we used the HADS to
evaluate the anxiety and depression symptoms of each
caregiver. The HADS is composed of 14 items, seven of
which relate to anxiety symptoms and seven concern
depression symptoms. Each item is coded from 0 to 3.
Therefore, the total scores for anxiety symptoms and
depression symptoms can both vary from 0 to 21, repre-
senting the presence and severity of the symptoms. We
used the score of 8 to define “caseness” for both anxiety
symptoms and depression symptoms [43, 48, 49].
Four experienced neurologists and one neuropsycholo-
gist (QG, DD, QZ, FL, and ZH) who work at top institu-
tions of neurology in China (Huashan Hospital and
Fuxing Hospital) reviewed the functional, medical,
neurological, psychiatric, and neuropsychological data,
and reached a consensus regarding the Diagnostic and
Statistical Manual of Mental Disorders-IV (DSM-IV)
criteria for dementia [50]. Only care-recipients who
were not diagnosed with dementia were considered for
a diagnosis of MCI based on the Petersen’s criteria
[51]. The other care-recipients were diagnosed with
SCD using a broad research criteria for pre-MCI SCD,
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which included two presentations: (1) the care-recipients
had to report self-experienced persistent decline in cogni-
tion compared to previous statue and that was unrelated
to an acute event; (2) care-recipients have normal age-,
gender-, and education-adjusted performance on stan-
dardized cognitive tests used to classify MCI.
Statistical analysis
Continuous variables were expressed as mean and standard
deviation (SD), and categorical variables were expressed
as frequencies (%). We divided all care-recipients and
caregivers into four groups according to the caregiver’s
performance on the HADS: with anxiety [anxiety(+)],
without anxiety [anxiety(−)], with depression [depres-
sion(+)], and without depression [depression(−)]. The
Wilcoxon rank sum test and the Kruskal-Wallis H rank
sum test were used to compare continuous variables,
whereas Pearson Chi-squared test was used to compare
categorical variables. Backward logistic regression
models were used to explore risk factors for anxiety
and depression symptoms among caregivers. Risk fac-
tors were presented as odds ratio (OR) with 95% confi-
dence interval (95 % CI). The possible risk factors we
adjusted for care-recipients included their gender, age,
education, diagnosis, and presence of stroke as well as
their IQCODE, TEQ, CMAI, GDS, ZSAS and AES
scores; those for caregivers included their gender, age,
education level, working status, and experience in car-
ing for care-recipients with dementia as well as their
familiarity with the care-recipient and their relationship
with the care-recipient. Two-tailed tests were used for
all analyses at a significance level of P < 0.05. The data
were analyzed using SAS 9.3 (SAS Institute Inc., Cary,
NC, USA).
Results
The demographic, medical history, neurology tests, psy-
chiatric assessment and neuropsychological assessment
data of the 343 pairs of care-recipients and caregivers
are shown below.
Comparison of caregiver characteristics between
caregiver groups with or without anxiety and depression
Totals of 17.9, 30.0 and 28.8 % of caregivers of care-
recipients with SCD, MCI or dementia had anxiety
symptoms (P = 0.1140), respectively; 22.6, 24.2 and 20.9 %
of these caregivers had depression symptoms (P = 0.8165),
respectively. Although caregivers of care-recipients with
SCD had relatively low anxiety symptoms and relatively
high depression symptoms, anxiety or depression symp-
toms were not associated with cognitive impairment
severity (Table 1).
Table 1 also shows that 146 (43.7 %) caregivers were
men, and the mean age was 55.0 (SD 16.4) years. The
education levels of the caregivers included illiteracy
(49, 14.7 %), primary education (73, 21.9 %), middle
education (154, 46.3 %), junior and college education
(15, 4.5 %), and university and higher education (42,
12.6 %). The following caregiver characteristics signifi-
cantly differed: gender and education level regarding
anxiety symptoms, and education level and age regard-
ing depression symptoms. When caregivers were
women or had low education levels, they were more
likely to have anxiety symptoms; when caregivers were
older or had low education levels, they were more
likely to have depression symptoms.
Comparison of care-recipient characteristics between
caregiver groups with or without anxiety and depression
A total of 84 (24.5 %) care-recipients had SCD, 120
(35.0 %) had MCI, and 139 (40.5 %) had mild to moder-
ate dementia (Table 1). Their mean age was 66.5 (SD
10.6) years. Moreover, 53.9 % were men, and their mean
years of education were 8.9 (SD 3.6) years. The
IQCODE, TEQ, CMAI, AES, ZSAS and GDS scores of
care-recipients significantly differed between the two
groups of caregivers with or without anxiety symptoms.
Compared with the care-recipients of caregivers with-
out anxiety symptoms, those of caregivers with anxiety
symptoms had higher IQCODE scores (55.6 vs 50.8),
lower TEQ scores (38.0 vs 41.8), higher CMAI scores
(41.5 vs 35.4), lower AES scores (27.1 vs 31.6), higher
ZSAS scores (36.9 vs 34.7) and higher GDS scores (6.5
vs 4.7s). The TEQ, CMAI, AES and GDS scores of
care-recipients significantly differed between the groups
of caregivers with or without depression symptoms.
Compared with the care-recipients of caregivers with-
out depression symptoms, those of caregivers with
depression symptoms had lower TEQ scores (38.1 vs
41.5), higher CMAI scores (39.3 vs 36.3), lower AES
scores (26.6 vs 31.5) and higher GDS scores (6.1 vs 4.9)
(Table 2).
Possible risk factors for caregiver’s anxiety and
depression symptoms
After adjusting the possible risk factors (gender, age,
education, presence of stroke, and diagnosis as well as
the IQCODE, TEQ, CMAI, GDS, ZSAS and AES scores
for care-recipients; and gender, age, education level,
working status, experience caring for care-recipients
with dementia, familiarity with the care-recipient and re-
lationship with the care-recipient for caregivers), we
found that possible risk factors for caregiver’s anxiety
symptoms were having a male care-recipient (OR = 2.19,
95 % CI:1.07–4.48), a higher CAMI score (OR = 1.06, 95 %
CI: 1.02–1.10), a higher GDS score (OR = 1.15, 95 %
CI:1.05–1.27) and increased caregiver age (OR = 1.02, 95 %
CI:1.00–1.05). The risk factors for caregiver’s depression
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symptoms were having a lower TEQ score (OR= 1.07, 95 %
CI:1.02–1.11), a care-recipient with MCI(OR= 2.76, 95 %
CI:1.11–6.88) or SCD(OR= 3.40, 95 % CI:1.16–10.01) com-
pared with one with dementia, a higher GDS score
(OR = 1.13, 95 % CI:1.03–1.24) and increased caregiver
age (OR = 1.02, 95 % CI:1.00–1.05) (Table 3).
Discussion
In our study, 26.5 % of caregivers had anxiety symptoms,
and 22.4 % had depression symptoms. For caregivers of
care-recipients with dementia, MCI or SCD, the rates of
anxiety symptoms in were 28.8, 30.0 or 17.9 %, respect-
ively; whereas the rates of depression symptoms were
20.9, 24.2 or 22.6 %, respectively. The risk factors for
caregiver’s anxiety symptoms were higher CMAI scores,
higher GDS scores, increased caregiver age and having a
male care-recipient. The risk factors for caregiver’s de-
pression symptoms were lower TEQ scores, higher GDS
scores, increased caregiver age and caring for care-
recipients with SCD or MCI.
The prevalence of depression symptoms among care-
givers of care-recipients with SCD or MCI was higher
than that among caregivers of care-recipients with
dementia. The prevalence of anxiety and depression
symptoms among caregivers of care-recipients with de-
mentia was in accordance with that in previous studies
[4, 6, 52]. The pooled depression rate of caregivers of
care-recipients with MCI (CESD scores ≥ 16 or equiva-
lent, total N = 929) was 23 % (11–24.6 % for individual
studies) [12], which is in accordance with our results.
One study suggested that dementia plays a significant
role in caregiver’s depression among Latino families
compared with cognitive impairment but not dementia
(CIND) [53]. However, most studies have found that de-
pression and anxiety symptoms among caregivers of
care-recipients with dementia are not associated with
level of cognitive impairment [54–56]. Another study
showed that cognitive function and dementia severity
were not correlated with caregiver burden [57]. One
possible explanation for our findings is that care-
recipients with SCD might often complain about their
own declining memory and refer to the effect of their
declining memory on activities of daily living. These
complaints draw the attention of caregivers and require
Table 1 Comparison of caregiver characteristics between caregiver groups with or without anxiety and depression
All Anxiety (+) Anxiety (−) P-value Depression (+) Depression (−) P-value
Total prevalence, n (%) 343 91 (26.5) 252 (73.5) 77 (22.4) 266 (77.6)
Prevalence of caregivers of
care-recipients with, n (%)
0.1140 0.8165
SCD 84 (24.5) 15 (17.9) 69 (82.1) 19 (22.6) 65 (77.4)
MCI 120 (35.0) 36 (30.0) 84 (70.0) 29 (24.2) 91 (75.8)
Dementia 139 (40.5) 40 (28.8) 99 (71.2) 29 (20.9) 110 (79.14)
Gender, male, n (%) 146 (43.7) 30 (34.5) 116 (47.0) 0.0436 33 (45.8) 113 (43.1) 0.6821
Age, years, mean(SD) 55.0 (16.4) 57.5 (15.1) 54.1(16.8) 0.1204 58.8 (14.9) 53.9 (16.7) 0.0290
Education level 0.0444 0.0394
Illiteracy, n (%) 49 (14.7) 16 (32.7) 33 (67.4) 14 (28.6) 35 (71.4)
Primary, n (%) 73 (21.9) 18 (24.7) 55 (75.3) 18 (24.7) 55 (75.3)
Middle, n (%) 154 (46.3) 43 (27.9) 111 (72.1) 30 (19.5) 124 (80.5)
Junior and college, n (%) 15 (4.5) 5 (33.3) 10 (66.7) 5 (33.3) 10 (66.7)
University and higher, n (%) 42 (12.6) 4 (9.5) 38 (90.5) 4 (9.5) 38 (90.5)
Relationship with care-recipient 0.6361 0.3128
Spouse, n (%) 176 (52.1) 47 (26.7) 129 (73.3) 43 (24.4) 133 (75.6)
Child, n (%) 141 (41.7) 35 (24.8) 106 (75.2) 26 (18.4) 115 (81.6)
Other relative, n (%) 21 (6.2) 5 (23.8) 16 (76.2) 4 (19.0) 17 (81.0)
Experience, n (%) 29 (9.2) 5 (6.1) 24 (10.3) 0.2616 8 (12.3) 21 (8.4) 0.3266
Work, n (%) 175 (52.9) 40 (46.0) 135 (55.3) 0.1336 34 (47.2) 141 (54.4) 0.2778
Familiarity with the care-recipient 0.3732 0.6333
Know well, n (%) 185 (58.0) 45 (24.3) 140 (75.7) 39 (21.1) 146 (78.9)
Partially know, n (%) 120 (37.6) 38 (31.7) 82 (68.3) 29 (24.2) 91 (75.8)
Know little, n (%) 14 (4.4) 3 (21.4) 11 (78.6) 3 (21.4) 11 (78.6)
Abbreviation: SD: standard deviation; SCD: subjective cognitive decline; MCI: mild cognitive impairment. P-values concern the between-group comparisons of
caregivers based on whether they are anxious or depressed
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support and care. When caregivers hear the complaint
about declining memory from care-recipients who didn’t
previously complain, and are unable to access the sup-
port that care-recipients need, caregivers might feel de-
pressed. Another possible explanation is that prior to
diagnosis, psychiatric symptoms are more stressful to
caregivers because their etiology is unclear, leading to
higher caregiver’s depression. After diagnosis, psychiatric
symptoms are likely attributed to the process of MCI.
With the care-recipient’ further cognitive decline, how-
ever, the caregivers become familiar with the disease,
able to care for the care-recipients and able to accept
the current situation. A third reason might be that care-
recipients with mild or moderate dementia, not the
severe dementia observed in our study, have relatively
mild mental symptoms and do not become a heavy bur-
den on their caregivers.
We found that care-recipient GDS scores were a risk
factor for both anxiety and depression symptoms among
caregivers; however, we did not find that care-recipient
ZSAS or AES scores were associated with caregiver’s
anxiety or depression symptoms. Most studies have
found that depression and anxiety symptoms in care-
givers of people with dementia are strongly associated
with patients’ psychiatric symptoms, particularly, depres-
sion symptoms [55, 58–62]. Furthermore, we found that
older caregivers had higher risks of both anxiety and de-
pression symptoms. In an Italian multicenter study of
419 elderly outpatients with dementia and their care-
givers, increased caregiver age was a major risk factor
for both depression and anxiety (BDDA) among care-
givers [63]. However, another study of caregivers of
people with cognitive impairment did not find that age
was an important predictor of caregiver’s anxiety [6, 64].
This finding might be because the physical functions of
older caregivers are worse; thus, they become anxious
and depressed given the increased burden.
Our study showed that care-recipient CMAI scores
were only related to caregiver’s anxiety symptoms. A
study of 35 patient-caregiver pairs evaluated at two
Table 2 Comparison of care-recipient characteristics between caregiver groups with or without anxiety and depression
All Anxiety (+) Anxiety (−) P-value Depression (+) Depression (−) P-value
Gender, male, n (%) 185 (53.9) 52 (57.1) 133 (52.8) 0.4740 45 (58. 4) 140 (52.6) 0.3677
Age, years, mean (SD) 66.5 (10.6) 67.0 (10.2) 66.3 (10.8) 0.5487 66.1 (11.0) 66.6 (10.5) 0.9714
Education, years, mean (SD) 8.9 (3.6) 9.2 (3.6) 8.9 (3.6) 0.4228 9.1 (3.6) 8.9 (3.6) 0.4911
Stroke, n (%) 59 (17.3) 19 (20.9) 40 (15.9) 0.2850 16 (20.8) 43 (16.2) 0.3520
MMSE scores, mean (SD) 23.5 (5.1) 23.0 (5.5) 23.6 (4.9) 0.4748 23.4 (5.3) 23.5 (5.0) 0.8552
MES scores, mean (SD) 64.2 (22.0) 62.4 (21.9) 64.8 (22.0) 0.3024 61.2 (23.8) 65.1 (21.4) 0.2618
IQCODE scores, mean (SD) 52.0 (15.3) 55.6 (14.0) 50.8 (15.6) 0.0120 53.6 (17.2) 51.6 (14.8) 0.1663
TEQ scores, mean (SD) 40.8 (8.8) 38.0 (8.0) 41.8 (8.9) < 0.0008 38.1 (8.0) 41.5 (8.9) 0.0041
CMAI scores, mean (SD) 37.0 (10.1) 41.5 (12.1) 35.4 (8.8) < 0.0001 39.3 (11.1) 36.3 (9.8) 0.0135
AES scores, mean (SD) 30.4 (13.4) 27.1 (13.1) 31.6 (13.4) 0.0078 26.6 (13.6) 31.5 (13.2) 0.0077
ZSAS scores, mean (SD) 35.2 (7.2) 36.9 (7.8) 34.7 (6.9) 0.0212 35.5 (7.4) 35.2 (7.2) 0.7837
GDS scores, mean (SD) 5.2 (3.7) 6.5 (3.9) 4.7 (3.6) 0.0003 6.1 (3.7) 4.9 (3.7) 0.0138
Abbreviation: SD standard deviation, MMSE Mini Mental State Examination, MES Memory and Executive Screening; IQCODE Informant Questionnaire on Cognitive
Decline in the Elderly, TEQ Toronto Empathy Questionnaire, CMAI Cohen-Mansfield Agitation Inventory, AES Apathy Evaluation Scale, ZSAS Zung Self-Rating Anxiety
Scale, GDS Geriatric Depression Scale. P-values concern the between-group comparisons of caregivers based on whether they are anxious or depressed
Table 3 Possible risk factors for caregiver’s anxiety and depression symptoms
Anxiety (+) Depression (+)
Variables OR (95 % CI) Variables OR (95 % CI)
Male care-recipient vs
Female care-recipient






CMAI (scores, increasing) 1.06 (1.02,1.10) TEQ (scores, decreasing) 1.07 (1.02,1.11)
GDS (scores, increasing) 1.15 (1.05,1.27) GDS (scores, increasing) 1.13 (1.03,1.24)
Age of caregivers (years, increasing) 1.02 (1.00,1.05) Age of caregivers (years, increasing) 1.02 (1.00,1.05)
Notes: Multivariate logistic regression model adjusted for the gender, age, education, presence of stroke, and diagnosis as well as the IQCODE, TEQ, CMAI, GDS,
ZSAS and AES scores of care-recipients; the model also adjusted for the gender, age, education level, and working status of caregivers as well as their experience
caring for care-recipients with dementia, familiarity with the care-recipient and relationship with the care-recipient
Abbreviations: OR odds ratio, CI confidence interval, MCI mild cognitive impairment, SCD subjective cognitive decline, CMAI Cohen-Mansfield Agitation Inventory,
GDS Geriatric Depression Scale, TEQ Toronto Empathy Questionnaire
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university-affiliated dementia clinics found highly signifi-
cant correlations between patient agitation and caregiver
burden (r = 0.59, p = 0.0002) as well as between depres-
sion and caregiver’s depression (r = 61, p = 0.0001) [65].
A Chinese study found a positively correlation between
the agitation among patients with dementia in nursing
homes and the stress of 40 nursing staff members [66].
The reason for this finding might be that in addition to
the constant daily care they provide, nursing staff must
also spend more energy and time preventing care-
recipient' self-harm and harm to others. If these effects
cannot be predicted or prevented, then it might lead to
serious consequences, and make caregivers feel persist-
ently anxious. Furthermore, our study also showed that
caregivers of males were more likely to suffer from anx-
iety symptoms, unlike previous studies. A previous study
[61] found that female caregivers were more likely to ex-
perience psychological distress. The LASER-AD study
found that being a female caregiver predicted having an
anxiety disorder [67]. Our result might be because males
are the core members of Chinese families; however, they
are more impulsive and harder to control. Caregivers
must take on more responsibilities (e.g., physical or fi-
nancial problems) than before, which might result in
caregiver’s anxiety symptoms.
We also found that care-recipient TEQ scores were a
risk factor for caregiver’s depression symptoms. Previous
studies have not investigated the relationship between
empathy and depression symptoms. One possible reason
might be that cognitive impairment is difficult to treat
with either behavioral or pharmacologic methods, leading
to embarrassment among care-recipients, which might
contribute to caregivers’ feelings of social isolation.
In our study, some characteristics of caregiver (i.e.,
gender, education level, the caregiver’s working status,
experience in caring for care-recipients with dementia, famil-
iarity with the care-recipient and their relationship with the
care-recipient) were not associated with caregiver’s anxiety
and depression symptoms. Having less education was
significantly associated with depression of caregivers of
care-recipients with MCI in two [68, 69] of three stud-
ies [68–70]. Caregiver gender [70–72] and relationship
with care-recipients [69, 70] did not predict depression
of caregivers of care-recipients with MCI. Having less
dementia knowledge significantly predicted depression
of caregivers of care-recipients with MCI [70]. Depres-
sion of caregivers of care-recipients with dementia or
cognitive impairment without dementia was associated
with whether the caregiver was the care-recipient’s spouse,
and whether the care-recipient had dementia or CIND
[73]. The reason may be that we studied the anxiety and
depression symptoms among caregivers of care-recipients
with subjective cognitive decline and cognitive impair-
ment, not only with cognitive function impairment.
To our knowledge, this study is the first to report the
prevalence of and risk factors for anxiety and depression
symptoms among the caregivers of care-recipients with
SCD. The first limitation of our study is that the cross-
sectional design limits any conclusions in a causal or
predictive direction. Future work should examine these
relationships longitudinally to more fully characterize
the direction of cause and effect. Second, we adjusted
for as many risk factors as possible in the logistic re-
gression model; however, we can’t exclude the possible
influence of uncollected risk factors such as the specific
care time of caregivers, alcohol drinking habits, disease
history (e.g., like head injury, coronary heart disease,
hypertension and diabetes), economic status, physical
and psychological illness among caregivers, and drugs
that affect mental health. Third, there are only care-
recipients with mild or moderate dementia, not the se-
vere dementia in our study, but care-recipients with the
severe dementia may cause serious impacts on their
caregivers.
Conclusions
Our study suggests that clinicians should be aware of
high rates of anxiety and depression symptoms among
caregivers of care-recipients with SCD or MCI. We
should also attend to the risk factors for anxiety and
depression symptoms among caregivers such as care-
recipient depressions, empathy and agitation. Further-
more, many caregivers require more social support via
training as well as physical and mental health care.
Such programs should provide caregivers with support
to address their burden and educate them learn about
cognitive impairment.
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